Upgrade to SI Premium - Free Trial

Definium Therapeutics (DFTX)

38.09 +0.09 (0.24%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/6/26 *Est.)

Latest Headlines

Stifel Reiterates Buy Rating on Definium Therapeutics Inc (DFTX) September 2, 2026 8:50 AM - StreetInsider Definium Therapeutics (DFTX) call put ratio 1 call to 1.9 puts as share price down 3.6% August 31, 2026 3:13 PM - StreetInsider Stifel Reiterates Buy Rating on Definium Therapeutics Inc (DFTX) August 31, 2026 9:25 AM - StreetInsider Stifel on Definium Therapeutics (DFTX) Post Mgmt Dinner Meet: 'Confident Overall in Regulatory/Commercial Dynamics' August 31, 2026 5:16 AM - StreetInsider Definium Therapeutics to Participate at Upcoming Investor Conferences and Events August 26, 2026 7:01 AM - BizWire BofA Securities Starts Definium Therapeutics Inc (DFTX) at Buy August 17, 2026 4:53 PM - StreetInsider Definium Therapeutics Announces New Employee Inducement Grants August 17, 2026 4:01 PM - BizWire Form SCHEDULE 13G/A Definium Therapeutics, Filed by: Commodore Capital LP August 14, 2026 4:14 PM - SEC Filing Definium Therapeutics Inc (DFTX) PT Raised to $55 at Maxim Group August 14, 2026 8:32 AM - StreetInsider Form SCHEDULE 13G/A Definium Therapeutics, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC August 14, 2026 7:35 AM - SEC Filing Definium Therapeutics Inc (DFTX) PT Raised to $72 at Wells Fargo August 13, 2026 8:42 AM - StreetInsider Definium Therapeutics Inc (DFTX) PT Raised to $66 at RBC Capital August 13, 2026 7:28 AM - StreetInsider Definium Therapeutics Inc (DFTX) PT Raised to $64 at Canaccord August 13, 2026 6:45 AM - StreetInsider Definium Therapeutics Inc (DFTX) PT Raised to $75 at Baird August 12, 2026 3:56 PM - StreetInsider Form 4 Definium Therapeutics, For: Aug 12 Filed by: Karlin Daniel August 12, 2026 8:30 AM - SEC Filing Form 4 Definium Therapeutics, For: Aug 12 Filed by: Wiley Matthew T. August 12, 2026 8:30 AM - SEC Filing Form 4 Definium Therapeutics, For: Aug 12 Filed by: Roberts Brandi August 12, 2026 8:30 AM - SEC Filing Form 4 Definium Therapeutics, For: Aug 12 Filed by: Barrow Robert August 12, 2026 8:30 AM - SEC Filing Form 4 Definium Therapeutics, For: Aug 12 Filed by: Sullivan Mark August 12, 2026 8:30 AM - SEC Filing Form 8-K Definium Therapeutics, For: Aug 12 August 12, 2026 8:06 AM - SEC Filing Definium's LSD-based pill meets Phase 3 goals in anxiety disorder trial August 12, 2026 7:00 AM - StreetInsider Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder August 12, 2026 7:00 AM - BizWire Definium Therapeutics Inc (DFTX) PT Raised to $75 at Piper Sandler August 7, 2026 7:49 AM - StreetInsider Form 10-Q Definium Therapeutics, For: Jun 30 August 6, 2026 4:22 PM - SEC Filing Mind Medicine (DFTX) Misses Q2 EPS by 144c August 6, 2026 4:19 PM - StreetInsider Form 8-K Definium Therapeutics, For: Aug 06 August 6, 2026 4:16 PM - SEC Filing Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights August 6, 2026 4:01 PM - BizWire Helus Pharma names ex-Intra-Cellular president as CEO August 5, 2026 10:26 AM - StreetInsider A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout August 5, 2026 10:25 AM - Globe NewsWire Definium Therapeutics Announces New Employee Inducement Grants August 3, 2026 4:01 PM - BizWire Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026 July 30, 2026 4:01 PM - BizWire Wells Fargo sees psychedelics market reaching $11B by 2035 July 27, 2026 6:55 AM - StreetInsider Wells Fargo Starts Definium Therapeutics Inc (DFTX) at Overweight July 27, 2026 5:44 AM - StreetInsider Definium Therapeutics Inc (DFTX) PT Raised to $73 at Piper Sandler Ahead For DT120 July 24, 2026 6:55 AM - StreetInsider Definium Therapeutics Announces New Employee Inducement Grants July 20, 2026 4:01 PM - BizWire Definium Therapeutics launches GAD education program for providers July 16, 2026 7:01 AM - StreetInsider Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology July 16, 2026 7:00 AM - BizWire New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD) July 14, 2026 7:00 AM - BizWire Definium Therapeutics Inc (DFTX) PT Raised to $60 at Stifel July 7, 2026 4:32 PM - StreetInsider Definium Therapeutics Announces New Employee Inducement Grants July 6, 2026 4:01 PM - BizWire Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity June 30, 2026 9:00 AM - StreetInsider Definium Therapeutics Inc (DFTX) PT Lowered to $58 at Canaccord June 30, 2026 6:42 AM - StreetInsider Form 4 Definium Therapeutics, For: Jun 25 Filed by: Sullivan Mark June 26, 2026 4:30 PM - SEC Filing Form 4 Definium Therapeutics, For: Jun 25 Filed by: Wiley Matthew T. June 26, 2026 4:30 PM - SEC Filing Form 4 Definium Therapeutics, For: Jun 25 Filed by: Roberts Brandi June 26, 2026 4:30 PM - SEC Filing Form 4 Definium Therapeutics, For: Jun 25 Filed by: Barrow Robert June 26, 2026 4:30 PM - SEC Filing Form 4 Definium Therapeutics, For: Jun 25 Filed by: Karlin Daniel June 26, 2026 4:30 PM - SEC Filing Definium Therapeutics raises $805M in upsized public offering June 25, 2026 4:15 PM - StreetInsider Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares June 25, 2026 4:15 PM - BizWire Form 144 Definium Therapeutics, Filed by: Sullivan Mark June 25, 2026 4:10 PM - SEC Filing Form 144 Definium Therapeutics, Filed by: Wiley Matthew T. June 25, 2026 4:10 PM - SEC Filing Form 144 Definium Therapeutics, Filed by: Roberts Brandi June 25, 2026 4:08 PM - SEC Filing Form 144 Definium Therapeutics, Filed by: Karlin Daniel June 25, 2026 4:07 PM - SEC Filing Form 144 Definium Therapeutics, Filed by: Barrow Robert June 25, 2026 4:07 PM - SEC Filing Form 8-K Definium Therapeutics, For: Jun 22 June 24, 2026 5:15 PM - SEC Filing Form 424B5 Definium Therapeutics, June 24, 2026 5:10 PM - SEC Filing Definium Therapeutics prices $700M public offering at $34 per share June 23, 2026 9:57 PM - StreetInsider Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering June 23, 2026 9:57 PM - BizWire Definium Therapeutics Inc (DFTX) PT Raised to $74 at Jones Trading June 23, 2026 8:04 AM - StreetInsider Definium Therapeutics Inc (DFTX) PT Raised to $50 at Needham June 23, 2026 7:23 AM - StreetInsider Definium Therapeutics Inc (DFTX) PT Raised to $57 at Baird June 23, 2026 6:19 AM - StreetInsider Form 424B5 Definium Therapeutics, June 22, 2026 4:18 PM - SEC Filing Definium Therapeutics plans $500M public share offering June 22, 2026 4:01 PM - StreetInsider Definium Therapeutics, Inc. Announces Proposed Public Offering June 22, 2026 4:01 PM - BizWire Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer June 22, 2026 11:31 AM - StreetInsider Definium Therapeutics Inc (DFTX) PT Raised to $52 at Leerink June 22, 2026 10:20 AM - StreetInsider Form 4 Definium Therapeutics, For: Jun 22 Filed by: Sullivan Mark June 22, 2026 9:45 AM - SEC Filing Form 4 Definium Therapeutics, For: Jun 22 Filed by: Wiley Matthew T. June 22, 2026 9:45 AM - SEC Filing Form 4 Definium Therapeutics, For: Jun 22 Filed by: Karlin Daniel June 22, 2026 9:45 AM - SEC Filing Form 4 Definium Therapeutics, For: Jun 22 Filed by: Barrow Robert June 22, 2026 9:45 AM - SEC Filing Form 4 Definium Therapeutics, For: Jun 22 Filed by: Roberts Brandi June 22, 2026 9:45 AM - SEC Filing Form 8-K Definium Therapeutics, For: Jun 22 June 22, 2026 8:03 AM - SEC Filing Definium's LSD-based pill meets Phase 3 endpoints for depression June 22, 2026 7:00 AM - StreetInsider Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder June 22, 2026 7:00 AM - BizWire Definium Therapeutics to release Phase 3 MDD study results June 22 June 21, 2026 5:00 PM - StreetInsider Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026 June 21, 2026 5:00 PM - BizWire Form S-8 Definium Therapeutics, June 16, 2026 4:07 PM - SEC Filing Form 4 Definium Therapeutics, For: Jun 11 Filed by: GRYSKA DAVID W June 15, 2026 4:31 PM - SEC Filing Form 4 Definium Therapeutics, For: Jun 11 Filed by: CRYSTAL ROGER June 15, 2026 4:31 PM - SEC Filing Form 4 Definium Therapeutics, For: Jun 11 Filed by: Vallone Carol A June 15, 2026 4:30 PM - SEC Filing Form 4 Definium Therapeutics, For: Jun 11 Filed by: Adsett Roger June 15, 2026 4:30 PM - SEC Filing Form 4 Definium Therapeutics, For: Jun 11 Filed by: Krebs Andreas June 15, 2026 4:30 PM - SEC Filing Form 4 Definium Therapeutics, For: Jun 11 Filed by: Bruhn Suzanne Louise June 15, 2026 4:30 PM - SEC Filing Definium Therapeutics Announces New Employee Inducement Grants June 15, 2026 4:01 PM - BizWire Form 8-K Definium Therapeutics, For: Jun 11 June 12, 2026 4:30 PM - SEC Filing Full Article List